Chapter

Opiate Receptors and Antagonists

Part of the series Contemporary Neuroscience pp 67-80

Opioid Receptor Antagonist-Mediated Signaling in the Immune System

  • Jonathan MoormanAffiliated withDepartment of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University Email author 
  • , Zhi Qiang YaoAffiliated withDepartment of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University
  • , Edward J. BilskyAffiliated withDepartment of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State UniversityDepartment of Pharmacology, University of New England College of Osteopathic Medicine
  • , Deling YinAffiliated withDepartment of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University

* Final gross prices may vary according to local VAT.

Get Access

Abstract

An increased susceptibility to infectious diseases in the setting of opiate use has long been noted. Studies on the specific roles of opiates in immune cells using opioid agonists and antagonists reveal a broad array of effects that include altered T and B cell proliferation, antibody production, natural killer cell activity, and cytokine production. The complexity of these effects in the setting of multiple opioid receptor subtypes has only recently been recognized. Novel, receptor-specific opioid antagonists permit more robust studies on the protean effects of these agents on immune cells. This chapter will emphasize what is known about the biologic and clinical effects of opioids on immune function with a focus on the role of opioid antagonists.

Keywords

Opioids Immunity Antagonists Lymphocyte Infection